GLP-1 receptor agonist: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}}
{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}}
{| class="wikitable sortable" style="width:100%"
{| class="wikitable sortable" style="width:100%"
|+[[Dihydropyridine/ja|ジヒドロビリジン系]]
|-
|-
!一般名
!一般名